Members of Congress are preparing to probe COVID-19 vaccine development and other issues related to the shots.
The Select Subcommittee on the Coronavirus Pandemic is planning to investigate how possible side effects are being studied, the regulatory process of authorizing and approving the vaccines, and why the vaccines were mandated, members told The Epoch Times.
One goal of the committee is making sure the United States is prepared for future pandemics, “and that includes perfecting our vaccine development,” Rep. Mariannette Miller-Meeks (R-Iowa) told The Epoch Times via email. “In order to do so, we must have complete transparency in vaccine research, clinical trials and adverse reactions, and manufacturing.”
“I expect our oversight hearings will shed light on the FDA approval process, the potential for side effects, and ultimately the success rate and safety of the vaccine—each of which will help us to navigate future global health emergencies,” she added.
Rep. Rich McCormick (R-Ga.), another member, said the panel “will be performing a comprehensive review of how the vaccines were developed, approved, and mandated.”
McCormick, a doctor, is concerned about how data on possible side effects has been collected. He also wants to look into how children as young as 6 months old have been encouraged to get a primary series and at least one booster, “given the lack of scientific evidence for a benefit, coupled with real concerns about possible harm for an otherwise immune person.”
Children are at the least risk from COVID-19. Vaccines were cleared for kids for prevention of symptomatic COVID-19 based on immunogenicity data, or antibody production. Real-world data shows the vaccines provide transient protection against symptomatic infection. Children and others who have recovered from COVID-19 enjoy shielding against the disease, especially against severe illness, and some research has found that after recovery, people have a higher risk of vaccine side effects.
“People do deserve to know about the long term safety and efficacy of the vaccine. A lot of the things that were told to us, like ‘they prevent transmission’ and all of that, was not true. So people will have concerns and those concerns should be addressed,” Rep. Nicole Malliotakis (R-N.Y.), another member of the subcommittee, told The Epoch Times.
